BREAKING NEWS

F.D.A. regulators said the Pfizer vaccine's benefits outweigh its risks for 5- to 11-year-olds. Emergency authorization could come as early as next week.

Friday, October 22, 2021 10:56 PM EST

The F.D.A. analysis came on the same day that Pfizer posted data showing that the vaccine had a 90.7 percent efficacy rate in preventing symptomatic Covid-19 in a clinical trial of 5- to 11-year-olds.

Read the latest